Blueprint Medicines (BPMC)
NASDAQ:BPMC

Blueprint Medicines (BPMC) Similar Stocks

523 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ligand Pharma
$1.90B
19.93
56.54%
3 Buy
0 Hold
0 Sell
Strong Buy
$127.00
Neurocrine
$14.70B
40.16
45.55%
15 Buy
5 Hold
0 Sell
Strong Buy
$165.06
Agios Pharma
$2.75B
-7.69
86.11%
6 Buy
2 Hold
0 Sell
Strong Buy
$52.83
Xencor
$1.31B
-9.70
-12.36%
7 Buy
1 Hold
1 Sell
Moderate Buy
$35.25
Blueprint Medicines
$7.12B
-23.58
92.37%
9 Buy
4 Hold
1 Sell
Moderate Buy
$119.00

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
LGND
Ligand Pharma
106.01
38.57
57.19%
NBIX
Neurocrine
146.10
44.85
44.30%
AGIO
Agios Pharma
48.50
22.90
89.45%
XNCR
Xencor
21.27
-2.11
-9.02%
BPMC
Blueprint Medicines
113.69
53.95
90.31%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis